Deepak Sambhara, MD
Ophthalmology · Wausau, WINPI 1083024574
Payments from drug & device makers
Across 405 payments — averaging $4865.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ocular Therapeutix, Inc.$1.6M
- Apellis Pharmaceuticals, Inc.$132K
- Regeneron Healthcare Solutions, Inc.$98K
- Astellas Pharma US Inc$83K
- Regeneron$16K
- Genentech USA, Inc.$12K
- plus $26K from 13 others
Across 5 payments — averaging $2664.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$7K
- F. Hoffmann-la Roche AG$6K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ocular Therapeutix, Inc. | 110 | $1,603,542 |
| Apellis Pharmaceuticals, Inc. | 80 | $132,028 |
| Regeneron Healthcare Solutions, Inc. | 70 | $97,957 |
| Astellas Pharma US Inc | 59 | $83,288 |
| Regeneron | 16 | $15,680 |
| Genentech USA, Inc. | 20 | $11,814 |
| Astellas Pharma Global Development | 3 | $6,311 |
| Coherus Oncology, Inc. | 5 | $6,305 |
| F. Hoffmann-la Roche AG | 2 | $4,515 |
| AbbVie | 11 | $2,501 |
| ANI Pharmaceuticals, Inc. | 6 | $2,385 |
| Alcon Research LLC | 1 | $1,625 |
| Alimera Sciences, Inc. | 6 | $1,410 |
| Heidelberg Engineering, Inc. | 1 | $350 |
| Bausch & Lomb Americas Inc. | 5 | $283 |
| Mallinckrodt Hospital Products Inc. | 3 | $225 |
| Alcon | 1 | $92 |
| Genentech, Inc. | 3 | $91 |
| Harrow Eye, LLC | 3 | $68 |
How this compares
$1,970,472 in reported general payments places this provider in the 95th percentile of 337 ophthalmology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Wausau
- Maxwell WingelaarWausau$11K
- Susan KsiazekWausau$5K
- John FlatterWausau$3K
- Inder SinghRacine$3.4M
- Barbara BlodiMadison$2.1M
- Mihai MititeluMadison$775K
- John VukichWauwatosa$537K
- Kimberly StepienMadison$446K
- Michael AltaweelMadison$433K
- Jonathan ChangMiddleton$340K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.